艾瑞昔布原料药
Search documents
富士莱2024年营收净利双降,55岁董事长钱祥云薪酬82万元、连降两年
Sou Hu Cai Jing· 2025-04-22 22:37
Core Insights - Fujilai (SZ301258) reported a significant decline in financial performance for the year 2024, with total revenue of 429.47 million yuan, a decrease of 12.23% compared to 2023 [1][2] - The net profit attributable to shareholders dropped to 16.41 million yuan, reflecting an 85.38% decline year-on-year [1][2] - The company experienced a substantial loss in net profit after deducting non-recurring items, amounting to -8.92 million yuan, a decrease of 109.96% [1][2] Financial Performance - Total revenue for 2024 was 429,468,011.82 yuan, down from 489,292,586.96 yuan in 2023, marking a 12.23% decline [2][3] - Net profit attributable to shareholders was 16,406,148.23 yuan, compared to 112,181,787.31 yuan in 2023, a decrease of 85.38% [2][3] - The net profit after deducting non-recurring items was -8,924,873.45 yuan, down from 89,606,898.67 yuan in 2023, indicating a decline of 109.96% [2][3] - Operating cash flow net amount was 47,068,013.45 yuan, a decrease of 50.33% from 94,768,588.39 yuan in 2023 [2][3] Revenue Breakdown - Revenue from external sales was 211.23 million yuan, a decline of 31.39%, while domestic sales revenue increased by 20.31% to 218.24 million yuan [2][3] - Sulfuric acid series revenue was 276.48 million yuan, down 26.25% year-on-year [2][3] - The revenue from the raw material drug, Arixib, surged by 835.06% to 62.98 million yuan [2][3] Product and Business Segmentation - The pharmaceutical main business accounted for 99.19% of total revenue, with a total of 426,006,805.49 yuan, down 11.82% from the previous year [3] - The sulfuric acid series products contributed 64.38% of total revenue, while the phosphatidylcholine series and the dipeptide series accounted for 9.57% and 10.58%, respectively [3] - Other business segments saw a significant decline of 44.10%, contributing only 3.46 million yuan to total revenue [3] Company Leadership - The chairman of Fujilai is Qian Xiangyun, who has been in the role since August 2008 and has a background in various positions within the company and local government [4] - Qian Xiangyun's compensation has varied over the years, with a reported salary of 82.40 million yuan in 2024 [5][6]